Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis
Arthritis & Rheumatism, 04/06/09
Vandooren B et al. – Data show that the local inflammatory milieu is clearly different in spondylarthritis (SpA) vs RA peripheral arthritis. Synovitis in SpA, including that in PsA, is characterized by a selective decrease in M1-derived proinflammatory mediators, such as TNF-α and IL-1β.
Methods- Study to assess whether the differential infiltration with macrophage subsets was associated with a different local inflammatory milieu in SpA vs RA
- Effect of SpA and RA synovial fluid (SF) on macrophage polarization was tested in vitro on normal PBMC
- SF levels of classically activated macrophage (M1)-derived and alternatively activated macrophage (M2)-derived mediators were analyzed in:
- 47 pts with non-psoriatic SpA
- 55 with RA, and
- 15 with psoriatic arthritis (PsA)
- Paired synovial biopsy samples were analyzed histologically
- SF from SpA pts promoted preferential expression of the M2 markers CD163 and CD200R in vitro, even if SF levels of the prototypical M2-polarizing factors were not increased vs RA SF
- SpA synovitis displayed strongly reduced SF levels of M1-derived, but not M2-derived, mediators
- SF levels of M1-derived mediators correlated well with peripheral joint inflammation in RA
- However, neither these mediators nor IL-1α and IL-17 did so in SpA
- Of interest, the SF cytokine profile in PsA, a more destructive subtype of SpA, was similar to that in non-psoriatic SpA
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
The use of complementary and alternative medicine in outpatients with inflammatory rheumatic diseases in Sweden
Scandinavian Journal of Rheumatology , 11/17/09
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09
Agreement between quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis
Journal of Rheumatology, 11/18/09
Recreational Exercise in Rheumatic Diseases
International Journal of Sports Medicine, 10/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


